These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 37298922)
1. Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue. Yasuoka Y; Izumi Y; Sands JM; Kawahara K; Nonoguchi H Molecules; 2023 May; 28(11):. PubMed ID: 37298922 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of endogenous erythropoietin and exogenous ESAs by Western blotting. Yasuoka Y; Fukuyama T; Izumi Y; Yamashita T; Nakayama Y; Inoue H; Yanagita K; Oshima T; Yamazaki T; Uematsu T; Kobayashi N; Shimada Y; Nagaba Y; Mukoyama M; Sato Y; Sands JM; Kawahara K; Nonoguchi H Heliyon; 2020 Nov; 6(11):e05389. PubMed ID: 33195841 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control. Reichel C; Benetka W; Lorenc B; Thevis M Drug Test Anal; 2016 Nov; 8(11-12):1131-1137. PubMed ID: 27552163 [TBL] [Abstract][Full Text] [Related]
4. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE. Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation. Yasuoka Y; Fukuyama T; Izumi Y; Nakayama Y; Inoue H; Yanagita K; Oshima T; Yamazaki T; Uematsu T; Kobayashi N; Shimada Y; Nagaba Y; Mukoyama M; Yamashita T; Sato Y; Sands JM; Kawahara K; Nonoguchi H Physiol Rep; 2020 Jun; 8(12):e14485. PubMed ID: 32592328 [TBL] [Abstract][Full Text] [Related]
6. Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol. Reichel C; Erceg D; Lorenc B; Scheiblhofer V; Farmer L; Zanitzer K; Geisendorfer T; Gmeiner G; Thevis M Drug Test Anal; 2023 Feb; 15(2):163-172. PubMed ID: 33450134 [TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic beads-based isolation of erythropoietins from urine and blood for sports anti-doping control. Desharnais P; Naud JF; Ayotte C Drug Test Anal; 2017 Nov; 9(11-12):1744-1752. PubMed ID: 28994210 [TBL] [Abstract][Full Text] [Related]
8. Combined immuno-purification and detection of recombinant erythropoietins and activin receptor type II-Fc fusion proteins by isoelectric focusing for application in doping control. Martin L; Audran M; Marchand A Drug Test Anal; 2019 Jan; 11(1):168-172. PubMed ID: 30091846 [TBL] [Abstract][Full Text] [Related]
9. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158 [TBL] [Abstract][Full Text] [Related]
10. Introduction of a PEGylated EPO conjugate as internal standard for EPO analysis in doping controls. Reihlen P; Blobel M; Weiß P; Harth J; Wittmann J; Leenders F; Thevis M Drug Test Anal; 2024 Aug; 16(8):743-749. PubMed ID: 34905300 [TBL] [Abstract][Full Text] [Related]
11. A simple method to immunopurify erthyropoiesis stimulating agents from urine, aiming to optimize erythropoietin screening by SAR-PAGE. Heiland CE; Masquelier M; Bhuiyan H; Ericsson M Drug Test Anal; 2019 Nov; 11(11-12):1666-1674. PubMed ID: 31692286 [TBL] [Abstract][Full Text] [Related]
12. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry. Yu NH; Ho EN; Wan TS; Wong AS Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243 [TBL] [Abstract][Full Text] [Related]
13. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates. Reihlen P; Völker-Schänzer E; Majer B; Schänzer W Drug Test Anal; 2012 Nov; 4(11):813-7. PubMed ID: 22566398 [TBL] [Abstract][Full Text] [Related]
14. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections. Dehnes Y; Shalina A; Myrvold L Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107 [TBL] [Abstract][Full Text] [Related]
15. SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood. Reichel C; Abzieher F; Geisendorfer T Drug Test Anal; 2009 Nov; 1(11-12):494-504. PubMed ID: 20355164 [TBL] [Abstract][Full Text] [Related]
16. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control. Reichel C Drug Test Anal; 2010; 2(11-12):603-19. PubMed ID: 21204292 [TBL] [Abstract][Full Text] [Related]
17. Improved detection methods significantly increase the detection window for EPO microdoses. Martin L; Martin JA; Collot D; Hoang O; Audran M; Ericsson M; Marchand A Drug Test Anal; 2021 Jan; 13(1):101-112. PubMed ID: 32737925 [TBL] [Abstract][Full Text] [Related]
18. Identification of zinc-alpha-2-glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS. Reichel C J Mass Spectrom; 2008 Jul; 43(7):916-23. PubMed ID: 18576436 [TBL] [Abstract][Full Text] [Related]
19. The interference of heparin on IEF-PAGE of erythropoietins. Reichel C; Benetka E; Geisendorfer T; Scheiblhofer V; Abzieher F Drug Test Anal; 2010; 2(11-12):568-75. PubMed ID: 21204288 [TBL] [Abstract][Full Text] [Related]
20. Optimizing detection of erythropoietin receptor agonists from dried blood spots for anti-doping application. Heiland CE; Ericsson M; Pohanka A; Ekström L; Marchand A Drug Test Anal; 2022 Aug; 14(8):1377-1386. PubMed ID: 35322582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]